ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 228 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,375,566 | -87.5% | 209,960 | -67.9% | 0.85% | -65.4% |
| Q4 2020 | $34,985,000 | +52.4% | 654,414 | +17.6% | 2.46% | +24.9% |
| Q3 2020 | $22,956,000 | +38.2% | 556,514 | +62.4% | 1.97% | +29.4% |
| Q2 2020 | $16,609,000 | +65.6% | 342,663 | +44.3% | 1.52% | -20.8% |
| Q1 2020 | $10,032,000 | +62.3% | 237,450 | +64.4% | 1.93% | +108.9% |
| Q4 2019 | $6,180,000 | -64.9% | 144,450 | -81.6% | 0.92% | -52.2% |
| Q1 2018 | $17,604,000 | -48.3% | 783,424 | -30.8% | 1.93% | -54.7% |
| Q4 2017 | $34,076,000 | +10.0% | 1,131,722 | +37.6% | 4.26% | +6.7% |
| Q3 2017 | $30,980,000 | +1.1% | 822,392 | -25.2% | 3.99% | +19.1% |
| Q2 2017 | $30,646,000 | +32.8% | 1,098,809 | +63.7% | 3.35% | +24.3% |
| Q1 2017 | $23,073,000 | -32.0% | 671,113 | -43.0% | 2.70% | -28.3% |
| Q4 2016 | $33,932,000 | +1808.4% | 1,176,543 | +2004.8% | 3.76% | +2048.0% |
| Q3 2016 | $1,778,000 | +85.2% | 55,897 | +89.0% | 0.18% | +76.8% |
| Q2 2016 | $960,000 | -95.0% | 29,582 | -95.7% | 0.10% | -89.4% |
| Q1 2016 | $19,312,000 | – | 690,700 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |